Quick Takeaways
- AdvisorShares Trust filed SCHEDULE 13G/A for Enveric Biosciences, Inc. Common Stock, $0.01 par value (ENVB).
- Disclosed ownership: 1.7%.
- Date of event: 31 Dec 2025.
AdvisorShares Trust - 31 Dec 2025 SCHEDULE 13G/A Report for Enveric Biosciences, Inc. Common Stock, $0.01 par value (ENVB)
- Filing Manager
- AdvisorShares Trust
- Reporting Manager
- AdvisorShares Trust
- Symbol
- ENVB
- Shares outstanding
- 1,022,530 shares
- Disclosed Ownership
- 16,974 shares
- Ownership
- 1.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 05 Jan 2026, 12:39:01 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 03 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"AdvisorShares Trust disclosed 1.7% ownership in Enveric Biosciences, Inc. Common Stock, $0.01 par value (ENVB) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 03 Oct 2025.
- Current filing was accepted on 05 Jan 2026, 12:39.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| AdvisorShares Trust | 1.7% | 16,974 | 16,974 | 0 | /s/ Stefanie Little | Stefanie Little - Chief Compliance Officer |